共 15 条
[1]
Tokita H.(2003)Circulating KL-6 level at baseline is a predictive indicator for the occurrence of interstitial pneumonia during interferon treatment for chronic hepatitis C Hepatol Res 26 91-97
[2]
Fukui H.(2004)Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature Clin Infect Dis 39 1724-1729
[3]
Tanaka A.(2007)Acute exacerbation of idiopathic pulmonary fibrosis Chest 132 1652-1658
[4]
Midturi J.(2003)High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-α Am J Hematol 72 170-176
[5]
Sierra-Hoffman M.(1992)Acute exacerbation of lung disease during interferon alpha therapy for chronic hepatitis C Gastroenterology 102 1406-1408
[6]
Hurley D.(undefined)undefined undefined undefined undefined-undefined
[7]
Hyzy R.(undefined)undefined undefined undefined undefined-undefined
[8]
Huang S.(undefined)undefined undefined undefined undefined-undefined
[9]
Myers J.(undefined)undefined undefined undefined undefined-undefined
[10]
Steegmann J.L.(undefined)undefined undefined undefined undefined-undefined